
Sign up to save your podcasts
Or


This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?", featuring Beth Sweney, PA-C discusses the following topics:
Challenges in achieving treatment targets in AD
Therapeutic inertia and clinical implications of inadequate response
Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD
Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies
By LivDerm5
66 ratings
This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?", featuring Beth Sweney, PA-C discusses the following topics:
Challenges in achieving treatment targets in AD
Therapeutic inertia and clinical implications of inadequate response
Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD
Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies

135 Listeners

25,917 Listeners

113,520 Listeners

1,138 Listeners

17 Listeners

7,966 Listeners

195 Listeners

34 Listeners

145 Listeners

29,304 Listeners

51 Listeners

92 Listeners

6 Listeners

6 Listeners

32 Listeners